(Q33704295)

28 July 2017

1 reference

title

The role of allergen-specific T cells in the allergic immune response: relevance to allergy vaccination (English)

1 reference

28 July 2017

van Neerven RJ

1

1 reference

28 July 2017

publication date

1 June 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

54

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

552-561

1 reference

Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

T cells and eosinophils in the pathogenesis of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

CD80 costimulation is essential for the induction of airway eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

How do lymphocytes get into the asthmatic airways? Lymphocyte traffic into and within the lung in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Functional subsets of allergen-reactive human CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Fc epsilon RI-expressing antigen-presenting cells: new players in the atopic game

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Molecules involved in T-cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

T-cell responses to allergens: epitope-specificity and clinical relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Crossreactivity and T-cell epitope specificity of Bet v 1-specific T cells suggest the involvement of multiple isoallergens in sensitization to birch pollen

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

T-cell sensitization to epitopes from the house dust mites Dermatophagoides pteronyssinus and Euroglyphus maynei

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Analysis of T-cell reactive regions and HLA-DR4 binding motifs on the latex allergen Hev b 1 (rubber elongation factor).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Analysis of sequence polymorphism of a major mite allergen, Der p 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Sequence polymorphisms of the Der p 3 house dust mite allergen

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

PROPHYLACTIC INOCULATION AGAINST HAY FEVER

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

T cell clones specific for Bet v I, the major birch pollen allergen, crossreact with the major allergens of hazel, Cor a I, and alder, Aln g I

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

IL-5 production by allergen-stimulated T cells following grass pollen immunotherapy for seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Treatment of cat allergy with T-cell reactive peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Late response to allergen is associated with increased concentrations of tumor necrosis factor-alpha and IL-5 in induced sputum

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

T-cell cytokines in chronic allergic eye disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

High Frequency of IL-4–Producing CD4+ Allergen-Specific T Lymphocytes in Atopic Dermatitis Lesional Skin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Characterization of grass pollen reactive T-cell lines derived from lesional atopic skin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

A subset of CD8+ T cells from allergic patients produce IL-4 and stimulate IgE production in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Prostaglandin E2 control of T cell cytokine production is functionally related to the reduced lymphocyte proliferation in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Comparison of diversity and function of house dust mite-specific T lymphocyte clones from atopic and non-atopic donors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Class II major histocompatibility complex restriction of human T cell responses to short ragweed allergen, Amb a V.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Peptide-induced nonresponsiveness of HLA-DP restricted human T cells reactive with Dermatophagoides spp. (house dust mite).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Clonal analysis of the atopic immune response to the group 2 allergen of Dermatophagoides spp.: identification of HLA-DR and -DQ restricted T cell epitopes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Functional inactivation of Dermatophagoides spp. (house dust mite) reactive human T-cell clones.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Diversity of TCRAV and TCRBV sequences used by human T-cell clones specific for a minimal epitope of Bet v 1, the major birch pollen allergen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

T-cell epitopes of Phl p 1, major pollen allergen of timothy grass (Phleum pratense): evidence for crossreacting and non-crossreacting T-cell epitopes within grass group I allergens.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Parietaria judaica-specific T-cell clones from atopic patients: heterogeneity in restriction, V beta usage, and cytokine profile

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Identification of a highly promiscuous and an HLA allele-specific T-cell epitope in the birch major allergen Bet v 1: HLA restriction, epitope mapping and TCR sequence comparisons

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Recruitment of circulating allergen-specific T lymphocytes to the lung on allergen challenge in asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

In vivo clonal dominance and limited T-cell receptor usage in human CD4+ T-cell recognition of house dust mite allergens

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Overlapping T-cell epitopes in the group I allergen of Dermatophagoides species restricted by HLA-DP and HLA-DR class II molecules.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

An immunogenetic analysis of T-cell reactive regions on the major allergen from the house dust mite, Der p I, with recombinant truncated fragments

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Analysis of human T cell responses to the group II allergen of Dermatophagoides species: Localization of major antigenic sites

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Definition of the human T-cell epitopes of Fel d 1, the major allergen of the domestic cat.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Multiple T cell specificities forBet v I, the major birch pollen allergen, within single individuals. Studies using specific T cell clones and overlapping peptides

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Single amino acid substitutions on a Japanese cedar pollen allergen (Cry j 1)-derived peptide induced alterations in human T cell responses and T cell receptor antagonism

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

T cell epitopes of the major fraction of rye grass Lolium perenne (Lol p I) defined using overlapping peptides in vitro and in vivo. I. Isoallergen clone1A.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Mapping of T cell epitopes of the major fraction of rye grass using peripheral blood mononuclear cells from atopics and non‐atopics. II. Isoallergen clone 5A of Loliuum perenne group I (Lol p I)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Identification of T-cell epitope sequences on an important mite antigen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Immunodominance of seven regions of a major allergen, Cry j 2, of Japanese cedar pollen for T-cell immunity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Multiple B- and T-cell epitopes on a major allergen of Kentucky Bluegrass pollen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Mapping human T cell epitopes on phospholipase A2: the major bee-venom allergen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Establishment and characterization of ovalbumin-specific T cell lines from patients with egg allergy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Four Recombinant Isoforms of Cor a 1, the Major Allergen of Hazel Pollen, Show Different Reactivities with Allergen-specific T-lymphocyte Clones

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

The significance of isoallergenic variations in present and future specific immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Recombinant allergens

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Dissection of the grass allergen-specific immune response in patients with allergies and control subjects: T-cell proliferation in patients does not correlate with specific serum IgE and skin reactivity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Analysis of human T cell clones reactive with group V grass pollen allergens

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Immunologic changes associated with allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Fel d 1-specific IgG antibodies induced by natural exposure have blocking activity in skin tests

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

IgG subclass antibody response in grass pollen-allergic patients undergoing specific immunotherapy. Prognostic value of serum IgG subclass antibody levels early in immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-gamma production in CD4+ T cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Role of interleukin 10 in specific immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

IL-5 production by allergen-stimulated T cells following grass pollen immunotherapy for seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen-specific immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

Effects of peptide therapy on ex vivo T-cell responses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.1999.T01-1-00092.X

7 January 2021

10.1034/J.1398-9995.1999.T01-1-00092.X

Identifiers

DOI

1 reference

28 July 2017

1 reference